3VV: S-{(3R,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} (9Z)-octadec-9-enethioate (non-preferred name)
3VV is a Ligand Of Interest in 4PDK designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 4PDK_3VV_A_301 | 53% | 11% | 0.159 | 0.92 | 2.78 | 1.4 | 14 | 10 | 6 | 0 | 100% | 1 |
| 4PDK_3VV_A_302 | 23% | 12% | 0.224 | 0.85 | 2.8 | 1.37 | 14 | 10 | 9 | 0 | 100% | 1 |
| 4PDK_3VV_B_301 | 19% | 11% | 0.262 | 0.86 | 2.8 | 1.39 | 15 | 12 | 8 | 0 | 100% | 0.8358 |
| 4PDK_3VV_B_302 | 16% | 10% | 0.24 | 0.808 | 2.83 | 1.51 | 14 | 12 | 6 | 0 | 100% | 1 |
| 6WF2_3VV_B_403 | 27% | 10% | 0.281 | 0.933 | 2.88 | 1.46 | 17 | 13 | 11 | 0 | 100% | 1 |
